Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
University of Colorado, Denver · NCT07424365
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 1
- Study start
- May 19, 2025
- Record last updated
- February 20, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and other thinking abilities. This process, called transcutaneous auricular vagus nerve stimulation (taVNS), could help improve brain function in both healthy individuals and people with Parkinson's disease (PD).
Being studied: transcutaneous auricular vagus nerve stimulation; sham stimulation
Conditions: Mild Cognitive Impairment (MCI); Parkinsons Disease (PD); Healthy Adult
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals aged 18-65.
- Ability to sign informed consent.
- Ability to follow written and verbal instructions.
- For the PD group, a clinical diagnosis of Parkinson's disease without severe motor or cognitive impairments.
Exclusion Criteria
- Current uncontrolled and/or clinically significant medical condition.
- Abnormal ear anatomy or active ear infection.
- Electronic medical implants, such as pacemakers, cochlear prosthesis, neuro-stimulators.
- Uncorrected visual impairments that would interfere with task performance.
(6) Other significant diseases or disorders that might impair study participation.
Recruiting US locations
Clinical Translational Research Center at CU Anschutz
Aurora, CO 80045
Site contact: Colorado Clinical and Translational Sciences Institute · 303-724-1222 · CCTSI.Helpdesk@ucdenver.edu
Study contacts (from the official record)
- Elise R Carter · 3094335932 · elise.carter@cuanschutz.edu
Similar studies in Colorado
All neurology studies in Colorado →- RecruitingHealthy volunteers
100-Year Human Aging Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Human Observatory Study
Longevity Metrics, Inc.
- Location
- Boulder, CO
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Encoded Therapeutics
- Location
- Aurora, CO + 9 other US sites
- Eligibility basics
- Ages 6 mo–17
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Fort Collins, CO + 35 other US sites
- Eligibility basics
- Ages 18–65